Reading PE Value Creation ROI from Transaction Data

Private equity (PE) value creation programs are presented in board decks and measured in management reports. What they're almost never measured against is their actual return on program investment. The operating partner spends $400K on commercial consultants, $200K on new headcount for the sales ops team, and $150K on a new CRM configuration. Whether that $750K produced $1.5M in annual recurring revenue (ARR) lift or $15M in ARR lift is a question that doesn't get asked systematically. That absence of measurement is itself a value destruction event.

The Revenue at Stake

When you don't measure commercial program ROI, two things happen.

First, you repeat low-ROI interventions. The VP of Sales who ran a training program that moved no metrics runs the same program next year because the board never saw a number that told them it didn't work. The operating partner who hired two sales ops headcount to improve forecast accuracy never validates whether forecast accuracy actually improved or whether the improved revenue predictability came from a different source.

Second, you underfund high-ROI interventions. Pricing governance programs that generate 20 to 40x returns are regularly skipped because they feel intangible or politically difficult. If you'd seen the measured ROI from the last three PE companies that ran them, you'd know they're the most reliable commercial investment available. The measurement is the argument.

The Working Model

Program ROI = (ARR Delta Attributable to Program x Exit Multiple) / Total Program Cost

Step 1: Isolate the ARR delta. For each commercial program, define the specific metric it's designed to move and its starting value. Pricing governance program: starting effective concession rate 27%, target 18%. If ARR is $58M and you tighten concession rates by 9 points: ARR improvement = $58M x 9% = $5.22M annually. This is a maximum; apply a 70% execution probability to get $3.65M.

Step 2: Apply the exit multiple. At a 6x expected revenue exit multiple, $3.65M in annual ARR lift = $21.9M in enterprise value creation. If the hold period is 3 years, apply a present value discount: at 20% discount rate, $21.9M enterprise value in year 1, growing with ARR, present value roughly $52M over 3 years.

Worked example, four-program portfolio:

• Pricing governance (concession tightening): $3.65M ARR lift x 6x = $21.9M EV. Program cost: $180K. ROI: 122x
• Comp realignment (NRR improvement from 99% to 108%): $5.22M ARR lift from existing base x 6x = $31.3M EV. Program cost: $90K (comp redesign only, no headcount). ROI: 348x
• Churn diagnosis and remediation: $1.74M ARR retained annually x 6x = $10.4M EV. Program cost: $75K. ROI: 139x
• Customer success (CS) capacity reallocation: $2.9M ARR lift from segment-led net revenue retention (NRR) focus x 6x = $17.4M EV. Program cost: $0 (reallocation, no new spend). ROI: effectively infinite

Total value created: $81M enterprise value. Total program cost: $345K. Portfolio ROI: 235x.

Data sources: CRM deal data (for concession rate baseline), billing system (for NRR and churn), comp plan mechanics (for structural misalignment analysis), exit interview data (for churn attribution), comparable transaction multiples (for EV calculation).

Where the Plan Breaks

A PE operating partner at a portfolio company with $58M ARR ran four commercial programs over 24 months. None of them had a defined baseline metric, a target, or a post-program measurement framework.

At the 24-month board review, the operating partner presented narrative evidence of improvement, more disciplined deal approvals, better CRM hygiene, stronger quarterly business review (QBR) process. ARR had grown from $58M to $71M (22% growth). The board credited market expansion.

A post-hoc analysis commissioned for a potential secondary sale found that $8.2M of the $13M ARR growth was directly attributable to the commercial programs, not market expansion. The programs had returned approximately 24x their cost. Nobody knew.

Before: $58M ARR, four programs running without measurement, growth attributed to market. After (post-hoc attribution): $8.2M ARR growth attributed to commercial programs. Programs had cost $340K. 24x ROI that nobody measured during the hold period.

Steps for This Quarter

Write down the three commercial programs currently running in your portfolio. For each one, write: the specific metric it's designed to improve, the baseline value of that metric today, and the target value at 12 months.

If you can't write those three things in five minutes, you don't have a measurement framework. That's the first thing to build.

Assess Your Commercial Health

Related reading: How to Measure the ROI of Commercial Due Diligence and Stop Guessing Private Equity Value Creation.